Groundbreaking research is uncovering better ways to keep AIDS at bay

By |2017-04-25T18:03:51+00:00December 2nd, 2014|Pharma News|

The Biggest HIV/AIDS Research Breakthroughs Of 2014   http://www.huffingtonpost.com/2014/12/01/2014-hiv-aids-research_n_6251388.html

Comments Off on Groundbreaking research is uncovering better ways to keep AIDS at bay

STUDYOPS and OPTIMUS MEDICAL AWARDED 2 HIV TRIALS

By |2014-11-25T18:54:18+00:00November 25th, 2014|Pharma News|

Studyops and Optimus, San Francisco, CA. were awarded 2  Studies for patients with HIV. Screening will begin in January. Check out www.studyops.com for our contact information to answer any questions. Please welcome Optimus, Dr. Shawn Hassler and his team to the Studyops family.

Comments Off on STUDYOPS and OPTIMUS MEDICAL AWARDED 2 HIV TRIALS

C-Suite unrest in Big Pharma

By |2014-11-25T18:22:48+00:00November 25th, 2014|Pharma News|

http://www.fiercepharma.com/story/takedas-us-chief-bows-out-amid-management-shake/2014-11-25?utm_medium=nl&utm_source=internal Takeda Chief is out, EVP Lise Kingo at Novo is out, Allergan pruning the Executive offices, plenty of others. All the M&A buys pipelines, but surely does not guarantee FDA follow through. www.studyops.com

Comments Off on C-Suite unrest in Big Pharma

Health Experts: Say No to Randomized Trials Testing Ebola Drugs

By |2017-04-25T18:03:53+00:00November 24th, 2014|Pharma News|

Karla Burke Life Sciences Senior Marketing Specialist at Thomson ReutersTop Contributor Leading health experts said that having decided it is ethical to use non-approved products to help deal with the Ebola virus epidemic, it would be unethical if those drugs were administered in the context of randomized clinical trials. “No one insisted Western medical workers [...]

Comments Off on Health Experts: Say No to Randomized Trials Testing Ebola Drugs
Go to Top